Singapore’s NDR Medical expands APAC presence

Singapore’s NDR Medical, an interventional robotics startup, has extended its Asia-Pacific (APAC) presence with the launch of its fourth office in Tokyo, Japan. The new office will be managed by Dr Kazumi Taguchi, NDR’s newly appointed Chief Medical Officer in Japan & Assistant Professor and head of research in Nephro-urology at Nagoya City University. The new office will enable NDR to strengthen its partnerships with hospitals & collaborators in the Japanese market & adds to the company’s presence in the region alongside its headquarters in Singapore, as well as offices in Malaysia and China. NDR will launch its first multi-site trial in Japan for Automated Needle Targeting (ANT)-X with two university hospitals to evaluate the puncture superiority of ANT-X compared with conventional techniques. The trial is expected to commence in Q2 2022 & includes more than 100 patients. The trial will assist in obtaining Pharmaceuticals & Medical Devices Agency (PMDA) approval for later commercialisation in Japan.